임신 중 dimethyl imidazolidinone을 피해야 할까요? | VeriMom
Multiple supplier SDS and registration records list 1,3‑dimethyl‑2‑imidazolidinone (CAS 80‑73‑9, also called dimethylimidazolidinone, DMI) as Reproductive Toxicity Category 2 (H361, “suspected of damaging fertility or the unborn child”), and ECHA’s Registry of CLH intentions shows a CLH proposal has been submitted for this substance. These items support a suspected reproductive hazard (H361 → h=2) though a legally binding harmonised CLH entry does not appear to be published as an adopted harmonised classification yet; mechanistic data are limited, so mechanism is scored as theoretical only. DMI is a low‑molecular‑weight polar solvent with measurable dermal absorption in typical solvent roles, so topical cosmetic exposure is assessed as moderate. (Sources: ECHA substance page; ECHA Registry of CLH intentions; supplier SDS/C&L notifications; EWG summary).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- dimethyl imidazolidinone은 임신 중 안전한가요?
- Multiple supplier SDS and registration records list 1,3‑dimethyl‑2‑imidazolidinone (CAS 80‑73‑9, also called dimethylimidazolidinone, DMI) as Reproductive Toxicity Category 2 (H361, “suspected of damaging fertility or the unborn child”), and ECHA’s Registry of CLH intentions shows a CLH proposal has been submitted for this substance. These items support a suspected reproductive hazard (H361 → h=2) though a legally binding harmonised CLH entry does not appear to be published as an adopted harmonised classification yet; mechanistic data are limited, so mechanism is scored as theoretical only. DMI is a low‑molecular‑weight polar solvent with measurable dermal absorption in typical solvent roles, so topical cosmetic exposure is assessed as moderate. (Sources: ECHA substance page; ECHA Registry of CLH intentions; supplier SDS/C&L notifications; EWG summary).
- dimethyl imidazolidinone은 모유 수유 중 안전한가요?
- Same hazard basis as pregnancy (listed as Repr. Cat.2 / H361 in registration/SDS material and under active CLH proposal). Mechanism evidence is limited. Dermal/topical exposure could lead to systemic exposure (moderate expected dermal absorption), so breastfeeding exposure is scored as moderate (e=2) because systemic maternal exposure could lead to transfer into milk if maternal systemic levels occur.
- dimethyl imidazolidinone은 아기 피부에 안전한가요?
- Hazard and mechanism scores follow the same evidence (H361 / Repr. Cat.2 reporting and CLH proposal). Because DMI has measurable dermal absorption as a small polar solvent, infant skin (0–3 yr) receives a higher exposure score (+1 per guidance) relative to adults, so exposure is scored high. There is no specific infant toxicity data found to alter hazard or mechanism scores.
- VeriMom은 dimethyl imidazolidinone을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 dimethyl imidazolidinone을 20/100 (높은 위험)로 평가합니다.
- 임신 중 dimethyl imidazolidinone 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.